Search

Author/Creator Spratlin, Jennifer

1. 387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies. (9th November 2020)

Authors:
Lin, Chia-Chi; Garralda, Elena; Schöffski, Patrick; Hong, David; Siu, Lillian; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel; Cassier, Philippe; Sarantopoulos, John; Weickhardt, Andrew; Carvajal, Rich; Spratlin, Jennifer; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Changing Rates of Goals of Care Designations in Patients With Advanced Pancreatic Cancer During a Multifactorial Advanced Care Planning Initiative: A Real-World Evidence Study. Issue 6 (2nd June 2022)

Authors:
Anaka, Matthew; Lee, Minji; Lim, Elisa; Ghosh, Sunita; Cheung, Winson Y.; Spratlin, Jennifer
Journal:
JCO oncology practice
Issue:
Volume 18:Issue 6(2022)
Page Start:
e869
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019)

Authors:
Amin, Asim; Plimack, Elizabeth R.; Ernstoff, Marc S.; Lewis, Lionel D.; Bauer, Todd M.; McDermott, David F.; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I.; Heng, Daniel Y. C.; Knox, Jennifer; Voss, Martin H.; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer. (23rd July 2015)

Authors:
Chi, Kim N.; Spratlin, Jennifer; Kollmannsberger, Christian; North, Scott; Pankras, Catherine; Gonzalez, Martha; Bernard, Apexa; Stieltjes, Hans; Peng, Lixian; Jiao, James; Acharya, Milin; Kheoh, Thian; Griffin, Thomas W.; Yu, Margaret K.; Chien, Caly; Tran, Nam Phuong
Journal:
Journal of clinical pharmacology
Issue:
Volume 55:Number 12(2015:Dec.)
Page Start:
1406
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients. (October 2021)

Authors:
Yang, Ran; Younis, Moftah; Joseph, Kurian; Ghosh, Sunita; Nijjar, Tirath; Severin, Diane; Tankel, Keith; Tamhane, Yash; Fairchild, Alysa; Spratlin, Jennifer; Mulder, Karen; Usmani, Nawaid
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 27:Number 7(2021)
Page Start:
1596
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (22nd October 2018)

Authors:
Amin, Asim; Plimack, Elizabeth R; Ernstoff, Marc S; Lewis, Lionel D; Bauer, Todd M; McDermott, David F; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I; Heng, Daniel Y C; Knox, Jennifer; Voss, Martin H; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗